CRANBURY, New Jersey, October 29, 2024 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced a significant growth capital investment led by 1315 Capital, a Philadelphia-based, growth equity firm focused on healthcare, with participation from its […]
Read MoreCRANBURY, New Jersey, DUBLIN, Ireland, April 3, 2024 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced the appointment of Philip Dunne as Director of EU Operations, to head up initial operations of its recently announced […]
Read MoreCRANBURY, New Jersey, DUBLIN, Ireland, February 27, 2024 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, announced its new facility in Dublin, Ireland, to support global clinical trials. The opening of this depot will expand the Company’s […]
Read MoreCRANBURY, N.J.; Dec. 7 2023 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, announced today the addition of a Harro Höfliger Modu-C CS Containment at its New Jersey facility. The new equipment is the first capsule filling […]
Read MoreCRANBURY, N.J.; Oct. 5, 2023 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of a Series B extension round of financing. The additional capital is earmarked to support the company’s double-digit organic growth and […]
Read MoreCRANBURY, N.J.; Jan. 24, 2023 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced the expansion of its analytical laboratory and services. The new laboratory is located in the same office park as Experic’s headquarters in Cranbury, […]
Read MoreCRANBURY, N.J.; November 30, 2022 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, today announced the closing of a $14 million series B capitalization led by Harro Höfliger Packaging Systems, Inc. and East Seattle Partners. In addition, Experic has […]
Read MoreTORONTO (PRWEB) NOVEMBER 10, 2022 – There are a variety of reasons why companies want to accelerate pharma development & manufacturing timelines: to produce drug products for a clinical trial, make products for compassionate use, or meet a management commitment to serve patients, etc. While the primary motivating factor may differ […]
Read MoreCRANBURY, N.J., Sept. 20, 2022 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the pharmaceutical industry, today announced the appointment of Derek Hennecke as an independent member of its board of directors. “Mr. Hennecke’s distinctive combination of experience as an entrepreneur, board […]
Read MoreTORONTO – OCTOBER 12, 2021 – A robust approach for combination drug product development requires an understanding of the drug product characteristics, the effects of processing and device design and how they impact product performance. Risk management connects the dots and interactions of these critical factors. A key component of risk […]
Read More